Role of OGG1 Ser326Cys polymorphism and 8-oxoguanine DNA damage in risk assessment of squamous cell carcinoma of head and neck in north Indian population

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 726, Issue 2, 2011, Pages 227-233

  Kumar, Anil ^a   Pant, Mohan Chand ^b   Singh, Hirdya Shanker ^c   Khandelwal, Shashi ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c CH CHARAN SINGH UNIVERSITY   (India)

Author keywords

8 OHdG; Genetic susceptibility; Life style factors; OGG1 polymorphism; SCCHN

Indexed keywords

8 HYDROXYGUANINE; BIOLOGICAL MARKER; DNA GLYCOSYLTRANSFERASE; FREE RADICAL; GENOMIC DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; EARLY DIAGNOSIS; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; INDIA; LARYNX CARCINOMA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SALIVA ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA DAMAGE; DNA GLYCOSYLASES; FEMALE; GUANINE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 81055155889     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.09.015     Document Type: Article

References (71)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
2. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 2004, 567:447-474.
3. Asami S., Manabe H., Miyake J., Tsurudome Y., Hirano T., Yamaguchi R., Itoh H., Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997, 18:1763-1766.
4. Smith L.E., Denissenko M.F., Bennett W.P., Li H., Amin S., Tang M., Pfeifer G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 2000, 92:803-811.
5. Fan C.Y. Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. Curr. Oncol. Rep. 2001, 3:66-71.
6. Maier H., Born I.A., Veith S., Adler D., Seitz H.K. The effect of chronic ethanol consumption on salivary gland morphology and function in the rat. Alcohol. Clin. Exp. Res. 1986, 10:425-427.
7. Klungland A., Hoss M., Gunz D., Constantinou A., Clarkson S.G., Doetsch P.W., Bolton P.H., Wood R.D., Lindahl T. Base excision repair of oxidative DNA damage activated by XPG protein. Mol. Cell 1999, 3:33-42.
8. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science 2001, 291:1284-1289.
9. Kairupan C., Scott R.J. Base excision repair and the role of MUTYH. Hered. Cancer Clin. Pract. 2007, 5:199-209.
10. Nunoshiba T., Ishida R., Sasaki M., Iwai S., Nakabeppu Y., Yamamoto K. A novel Nudix hydrolase for oxidized purine nucleoside triphosphates encoded by ORFYLR151c (PCD1 gene) in Saccharomyces cerevisiae. Nucleic Acids Res. 2004, 32:5339-5348.
11. Hu Y.C., Ahrendt S.A. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer. Int. J. Cancer 2005, 114:387-393.
12. Sugimura H., Kohno T., Wakai K., Nagura K., Genka K., Igarashi H., Morris B.J., Baba S., Ohno Y., Gao C.M., Li Z.Y., Wang J.D., Takezaki T., Tajima K., Varga T., Sawaguchi T., Lum J.K., Martinson J.J., Tsugane S., Iwamasa T., Shinmura K., Yokota J. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1999, 8:669-674.
13. Ito H., Hamajima N., Takezaki T., Matsuo K., Tajima K., Hatooka S., Mitsudomi T., Suyama M., Sato S., Ueda R. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J. Epidemiol. 2002, 12:258-265.
14. Michaels M.L., Miller J.H. The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J. Bacteriol. 1992, 174:6321-6325.
15. Thomas D., Scot A.D., Barbey R., Padula M., Boiteux S. Inactivation of OGG1 increases the incidence of G:C→T:A transversions in Saccharomyces cerevisiae: evidence for endogenous oxidative damage to DNA in eukaryotic cells. Mol. Gen. Genet. 1997, 254:171-178.
16. Minowa O., Arai T., Hirano M., Monden Y., Nakai S., Fukuda M., Itoh M., Takano H., Hippou Y., Aburatani H., Masumura K., Nohmi T., Nishimura S., Noda T. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4156-4161.
17. Trapp C., Reite K., Klungland A., Epe B. Deficiency of the Cockayne syndrome B (CSB) gene aggravates the genomic instability caused by endogenous oxidative DNA base damage in mice. Oncogene (England) 2007, 4044-4048.
18. Isidro G., Laranjeira F., Pires A., Leite J., Regateiro F., Castro e Sousa F., Soares J., Castro C., Giria J., Brito M.J., Medeira A., Teixeira R., Morna H., Gaspar I., Marinho C., Jorge R., Brehm A., Ramos J.S., Boavida M.G. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum. Mutat. 2004, 24:353-354.
19. Guan Y., Manuel R.C., Arvai A.S., Parikh S.S., Mol C.D., Miller J.H., Lloyd S., Tainer J.A. MutY catalytic core, mutant and bound adenine structures define specificity for DNA repair enzyme superfamily. Nat. Struct. Biol. 1998, 5:1058-1064.
20. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R., Cheadle J.P. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat. Genet. 2002, 30:227-232.
21. Smith L.M., Sharif S., Brand R., Fink E., Lamb J., Whitcomb D.C. MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer. Pancreatology 2009, 9:793-796.
22. Wu C., Nagasaki H., Maruyama K., Nakabeppu Y., Sekiguchi M., Yuasa Y. Polymorphisms and probable lack of mutation in a human mutT homolog, hMTH1, in hereditary nonpoliposis colorectal cancer. Biochem. Biophys. Res. Commun. 1995, 214:1239-1245.
23. Yakushiji H., Maraboeuf F., Takahashi M., Deng Z.S., Kawabata S., Nakabeppu Y., Sekiguchi M. Biochemical and physicochemical characterization of normal and variant forms of human MTH1 protein with antimutagenic activity. Mutat. Res.: DNA Repair 1997, 384:181-194.
24. Bravard A., Vacher M., Moritz E., Vaslin L., Hall J., Epe B., Radicella J.P. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res. 2009, 69:3642-3649.
25. Stern M.C., Conti D.V., Siegmund K.D., Corral R., Yuan J.M., Koh W.P., Yu M.C. DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2363-2372.
26. Sliwinski T., Przybylowska K., Markiewicz L., Rusin P., Pietruszewska W., Zelinska-Blizniewska H., Olszewski J., Morawiec-Sztandera A., Mlynarski W., Majsterek I. MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study. Mol. Biol. Rep. 2011, 38:1251-1261.
27. Le Marchand L., Donlon T., Lum-Jones A., Seifried A., Wilkens L.R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:409-412.
28. Elahi A., Zheng Z., Park J., Eyring K., McCaffrey T., Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002, 23:1229-1234.
29. Srivastava A., Srivastava K., Pandey S.N., Choudhuri G., Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
30. Upadhyay R., Malik M.A., Zargar S.A., Mittal B. OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of northern India. J. Gastrointest. Cancer 2010, 41:110-115.
31. Agalliu I., Kwon E.M., Salinas C.A., Koopmeiners J.S., Ostrander E.A., Stanford J.L. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 2010, 21:289-300.
32. Li W.Q., Zhang L., Ma J.L., Zhang Y., Li J.Y., Pan K.F., You W.C. Association between genetic polymorphisms of DNA base excision repair genes and evolution of precancerous gastric lesions in a Chinese population. Carcinogenesis 2009, 30:500-505.
33. Gorgens H., Muller A., Kruger S., Kuhlisch E., Konig I.R., Ziegler A., Schackert H.K., Eckelt U. Analysis of the base excision repair genes MTH1, OGG1 and MUTYH in patients with squamous oral carcinomas. Oral Oncol. 2007, 43:791-795.
34. Baudhuin L.M., Roberts L.R., Enders F.T., Swanson R.L., Mettler T.A., Aderca I., Stadheim L.M., Highsmith W.E. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. J. Cancer Res. Clin. Oncol. 2006, 132:159-162.
35. Miyako K., Kohno H., Ihara K., Kuromaru R., Matsuura N., Hara T. Association study of human MTH1 gene polymorphisms with type 1 diabetes mellitus. Endocr. J. 2004, 51:493-498.
36. Kohno T., Sakiyama T., Kunitoh H., Goto K., Nishiwaki Y., Saito D., Hirose H., Eguchi T., Yanagitani N., Saito R., Sasaki-Matsumura R., Mimaki S., Toyama K., Yamamoto S., Kuchiba A., Sobue T., Ohta T., Ohki M., Yokota J. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 2006, 27:2448-2454.
37. Satoh J., Kuroda Y. A valine to methionine polymorphism at codon 83 in the 8-oxo-dGTPase gene MTH1 is not associated with sporadic Parkinson's disease. Eur. J. Neurol. 2000, 7:673-677.
38. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 2008, 87:3-20.
39. Quiñones L., Lucas D., Godoy J., Cáceres D., Berthou F., Varela N., Lee K., Acevedo C., Martínez L., Aguilera A.M., Gil L. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 2001, 174:35-44.
40. Sikdar N., Mahmud S.A., Paul R.R., Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett. 2003, 195:33-42.
41. Brugere J., Guenel P., Leclerc A., Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986, 57:391-395.
42. Karahalil B., Kocabas N.A. hOGG1 SER326CYS genetic polymorphism in a Turkish population. Arch. Toxicol. 2005, 79:377-380.
43. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
44. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
45. Jiao X., Huang J., Wu S., Lv M., Hu Y., Jianfu X., Su C., Luo B. Ce, hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int. J. Cancer 2007, 121:501-505.
46. Gangwar R., Manchanda P.K., Mittal R.D. Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica 2009, 136:163-169.
47. Thameem F., Puppala S., Lehman D.M., Stern M.P., Blangero J., Abboud H.E., Duggirala R., Habib S.L. The Ser(326)Cys polymorphism of 8-oxoguanine glycosylase 1 (OGG1) is associated with type 2 diabetes in Mexican Americans. Hum. Hered. (Basel) 2010, 97-101.
48. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl. Cancer Inst. 2003, 95:1312-1319.
49. Paz-Elizur T., Ben-Yosef R., Elinger D., Vexler A., Krupsky M., Berrebi A., Shani A., Schechtman E., Freedman L., Livneh Z. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res. 2006, 66:11683-11689.
50. Sampson J.R., Dolwani S., Jones S., Eccles D., Ellis A., Evans D.G., Frayling I., Jordan S., Maher E.R., Mak T., Maynard J., Pigatto F., Shaw J., Cheadle J.P. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003, 362:39-41.
51. Sliwinski T., Markiewicz L., Rusin P., Pietruszewska W., Olszewski J., Morawiec-Sztandera A., Mlynarski W., Majsterek I. Polymorphisms of the DNA base excision repair gene MUTYH in head and neck cancer. Exp. Oncol. 2009, 31:57-59.
52. Paz-Elizur T., Elinger D., Leitner-Dagan Y., Blumenstein S., Krupsky M., Berrebi A., Schechtman E., Livneh Z. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair 2007, 6:45-60.
53. Asami S., Hirano T., Yamaguchi R., Tomioka Y., Itoh H., Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res. 1996, 56:2546-2549.
54. Kiyosawa H., Suko M., Okudaira H., Murata K., Miyamoto T., Chung M.H., Kasai H., Nishimura S. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic. Res. Commun. 1990, 11:23-27.
55. Ke Y.B, Zhang Z.Z., Jiang Y.S., Zhuang Z.X., Li L., Lu W.Q., Wu T.C. Association of hOGG1 genotype with life style and oxidative DNA damage among Chinese ethnic populations. Arch. Toxicol. 2009, 83:663-668.
56. Jaiswal M., LaRusso N.F., Nishioka N., Nakabeppu Y., Gores G.J. Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res. 2001, 61:6388-6393.
57. Karahalil B., Emerce E., Koçer B., Han S., Alkiş N., Karakaya A.E. The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in Turkey. Arh. Hig. Rada Toksikol. 2008, 59:241-250.
58. Hashimoto T., Uchida K., Okayama N., Imate Y., Suehiro Y., Hamanaka Y., Ueyama Y., Yamashita H., Hinoda Y. Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma. Mol. Carcinogen. 2006, 45:344-348.
59. Malik M.A., Zargar S.A., Mittal B. Lack of influence of DNA repair gene OGG1 codon 326 polymorphisms of gastric cancer risk in the Kashmir valley. Asian Pac. J. Cancer Prev. 2010, 11:165-168.
60. Kuo H.W., Chou S.Y., Hu T.W., Wu F.Y., Chen D.J. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients. Mutat. Res. 2007, 631:62-68.
61. Vogel U., Nexo B.A., Wallin H., Overvad K., Tjonneland A., Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem. Genet. 2004, 42:453-460.
62. Rossner P., Terry M.B., Gammon M.D., Zhang F.F., Teitelbaum S.L., Eng S.M., Sagiv S.K., Gaudet M.M., Neugut A.I., Santella R.M. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:811-815.
63. Hansen R.D., Krath B.N., Frederiksen K., Tjønneland A., Overvad K., Roswall N., Loft S., Dragsted L.O., Vogel U., Raaschou-Nielsen O. GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat. Res. 2009, 664:13-19.
64. Li D.H, Suzuki H., Liu B.R., Morris J., Liu J., Okazaki T., Li Y.N., Chang P., Abbruzzese J.L. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin. Cancer Res. 2009, 15:740-746.
65. Hanaoka T., Yamano Y., Hashimoto H., Kagawa J., Tsugane S. A preliminary evaluation of intra- and interindividual variations of hOGG1 messenger RNA levels in peripheral blood cells as determined by a real-time polymerase chain reaction technique. Cancer Epidemiol. Biomarkers Prev. 2000, 9:1255-1258.
66. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol. 2006, 7:149-156.
67. Seitz H.K., Maurer B., Stickel F. Alcohol consumption and cancer of the gastrointestinal tract. Dig. Dis. 2005, 23:297-303.
68. Janssen K., Schlink K., Gotte W., Hippler B., Kaina B., Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser(326)/Cys(326). Mutat. Res.: DNA Repair 2001, 486:207-216.
69. Chen S.K., Hsieh W.A., Tsai M.H., Chen C.C., Hong A.I., Wei Y.H., Chang W.P. Age-associated decrease of oxidative repair enzymes, human 8-oxoguanine DNA glycosylases (hOgg1), in human aging. J. Radiat. Res. 2003, 44:31-35.
70. Hill J.W, Evans M.K. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res. 2006, 34:1620-1632.
71. Smart D.J., Chipman J.K., Hodges N.J. Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2'-deoxyguanosine. DNA Repair 2006, 5:1337-1345.